Supplemental Figure Legends 1-9 from BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14
Year: 2023
Type: supplementary-materials
Abstract: Figure S1. CSIOVDB Disease State Analysis. Figure S2. CSIOVDB histology and tumor grade analysis. Figure S3. Survival of ovarian cancer patients in CSIOVDB cohort with respect the ratio of BORIS/CTCF expression. Figure S4. Survival of ovarian cancer patients in TCGA cohort with respect to BORIS expression and the ratio of BORIS/CTCF expression. Figure S5. Survival of ovarian cancer patients in CSIOVDB cohort (high grade serous only) with respect to BORIS expression. Figure S6. Cellular morphology and proliferation analyses of FT282-EV and FT282-BORIS cells. Figure S7. Expression of BORIS in FT282 cells alters CTCF occupancy. Figure S8. Representative genome browser shots of CTCF and BORIS ChIP-seq tracks and RNA-seq tracks for FT282-EV and FT282-BORIS cells. Figure S9. Survival of ovarian cancer patients in CSIOVDB cohort with respect the (A) CHSY3 and (B) SERPINB2 expression.
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362493471